Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor

Jiang Li1, Xue-hui Zeng, Hao-yuan Mo

  • 1State Key Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-sen University, Guangzhou, China.

Plos One
|November 8, 2007
PubMed

Insights

Nasopharyngeal carcinoma (NPC) is linked to Epstein-Barr virus (EBV). This study found that while EBV-specific T-cells show defects in NPC patients, tumor-infiltrating lymphocytes are inactivated at the tumor site, hindering immune response.

Area of Science:

  • Immunology
  • Oncology
  • Virology

Background:

  • Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated cancer prevalent in Southern China.
  • Understanding the host immune response to EBV in NPC is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the phenotype and function of T-cells and tumor-infiltrating lymphocytes (TILs) in untreated NPC patients.
  • To determine if defects in EBV-specific immunity contribute to NPC development and progression.

Main Methods:

  • Analysis of circulating T-cell subsets (naïve, activated, regulatory) and NK-cells in NPC patients versus healthy donors.
  • Assessment of T-cell responses to EBV-specific epitopes (LMP1, LMP2) using HLA-A2 tetramers.
  • Expansion and functional analysis of TILs, including cytotoxicity and cytokine production (IFN-gamma).

Main Results:

  • NPC patients showed decreased circulating naïve T-cells and increased activated T-cells and NK-cells.
  • Reduced frequency of EBV-specific T-cells recognizing LMP1/LMP2 epitopes in patients.
  • TILs exhibited altered T-cell populations but lacked cytotoxic activity and IFN-gamma production upon specific stimulation, despite potential for reactivation from peripheral blood.

Conclusions:

  • EBV-specific T-cell responses are impaired in the peripheral blood of NPC patients.
  • Tumor-infiltrating lymphocytes in NPC are functionally inactivated at the tumor site, suggesting a mechanism of immune evasion.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...